SOX21 and lip and oral cavity carcinoma: (49) discovered that low expression of SOX21-AS1 was significantly associated with poor clinicopathological features and prognosis in oral cancer patients, proposing that SOX21-AS1 might reinforce other tumor suppressor mRNAs and might otherwise competitively bind to certain transcription factors, thus preventing oncogene transcription.